Biotech · Private company
Healios K.K.
Track this companyFree. Adds Healios K.K. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- MultiStemPhase 3 · ARDSClinicalTrials.gov · fetched Nov 12, 2026
- MultiStemPhase 3 · Ischemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
- AMI MultiStem cellsPhase 2 · Heart AttackClinicalTrials.gov · fetched Nov 12, 2026
- MultiStemPhase 2 · Acute Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- MultiStemPhase 2 · TraumaClinicalTrials.gov · fetched Nov 12, 2026
- ShamPhase 2 · Heart AttackClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response SyndromePHASE2 · UNKNOWN · started Nov 9, 2020ClinicalTrials.gov NCT04533464 · fetched Nov 12, 2026
- MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)PHASE2_PHASE3 · TERMINATED · started Apr 28, 2020ClinicalTrials.gov NCT04367077 · fetched Nov 12, 2026
- MultiStem® Administration for Stroke Treatment and Enhanced Recovery StudyPHASE3 · TERMINATED · started Jul 28, 2018ClinicalTrials.gov NCT03545607 · fetched Nov 12, 2026
- A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress SyndromePHASE1_PHASE2 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02611609 · fetched Nov 12, 2026
- A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial InfarctionPHASE2 · TERMINATED · started Dec 1, 2015ClinicalTrials.gov NCT02277613 · fetched Nov 12, 2026